From the Journals

Reassurance for women taking certolizumab during pregnancy

Publish date: April 6, 2018

 

FROM ARTHRITIS & RHEUMATOLOGY


The study was funded by UCB Pharma. One author was a contractor for, and three were employees of, UCB Pharma. Six authors declared grants, consulting fees, and other remuneration from pharmaceutical companies, including UCB Pharma.

SOURCE: Clowse MEB et al. Arthritis & Rheumatology. 2018 Apr 5. doi: 10.1002/art.40508.

Pages

Recommended Reading

Multigene test panel helps diagnose fetal skeletal abnormalities
MDedge Internal Medicine
Short cervical length more common among black women, and more predictive of preterm birth
MDedge Internal Medicine
Perfusion-only scan rules out PE in pregnancy
MDedge Internal Medicine
HCV infection tied to premature ovarian senescence and a high miscarriage rate
MDedge Internal Medicine
Bariatric surgery may adversely affect newborns
MDedge Internal Medicine
Interventions urged to stop rising NAS, stem Medicaid costs
MDedge Internal Medicine
FDA approves certolizumab label update for pregnancy, breastfeeding
MDedge Internal Medicine
Axial SpA disease activity remains mostly stable throughout pregnancy
MDedge Internal Medicine
MDedge Daily News: Why most heart failure may be preventable
MDedge Internal Medicine
Higher preconception blood pressure linked to pregnancy loss
MDedge Internal Medicine